MES- Manufacturing Execution System Archives - Honeywell LIFE SCIENCES Mon, 16 Mar 2026 08:11:32 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 How to Choose the Right MES or Manufacturing Operations Platform https://www.spartasystems.com/resources/how-to-choose-the-right-mes-or-manufacturing-operations-platform/ Sun, 15 Mar 2026 11:37:52 +0000 https://www.spartasystems.com/?post_type=resources&p=23404 Selecting an MES or manufacturing operations platform is a strategic decision with long term implications. In pharmaceutical and biotech manufacturing, the platform chosen influences compliance, scalability, data visibility and the ability to continuously improve operations.

The post How to Choose the Right MES or Manufacturing Operations Platform appeared first on Honeywell.

]]>

Choosing More Than Software

Rather than evaluating isolated features, organizations should assess how well a platform supports their overall manufacturing strategy. Who this matters to:

  • Operations: Execution consistency and scalability
  • Quality: Data integrity and inspection readiness
  • IT: Architecture, integration and lifecycle management
Start with Architecture 

Architecture sets the foundation for success. A modular approach allows manufacturers to deploy required capabilities today while retaining flexibility to expand over time.

Scalability across lines and sites, along with support for on‑premises, cloud or hybrid deployments, enables the platform to evolve alongside business demands and regulatory requirements.

Core Execution Capabilities

At its core, a manufacturing operations platform must support reliable production execution. Key capabilities typically include:

  • Electronic batch records (eBR)
  • Recipe and workflow management
  • Material tracking and weigh-and-dispense
  • Comprehensive execution history

These capabilities help standardize production, reduce manual documentation and support traceability across the manufacturing lifecycle.

Integration Readiness

Manufacturing environments are inherently interconnected. MES platforms must integrate with enterprise systems such as ERP and LIMS, as well as automation systems including DCS and PLCs.

Pre‑built connectivity and strong interoperability reduce integration complexity and help avoid fragmented, multi-vendor architectures that increase maintenance and risk.

Data Historians as a Foundation for Insight

A comprehensive data historian is essential for turning raw production data into insight. By combining batch and time‑series data, historians provide a complete view of both discrete and continuous processes.

This historical context enables advanced trending, comparison of production runs and more efficient investigations. Engineers and quality teams can move beyond what happened to understanding why it happened. 

Data, Visibility and Compliance

When execution data, visualization and historical context are unified, manufacturers can move from reactive performance management to proactive improvement. Operational intelligence supports faster root cause analysis, more informed collaboration across teams and continuous process refinement without compromising compliance.

OEE remains a useful indicator, but it is only the starting point. Operational intelligence is what turns performance data into sustained improvement.

Evaluating Total Cost of Ownership

Total cost of ownership extends beyond initial software licensing or implementation costs. Manufacturers should consider long-term system scalability, integration maintenance, vendor dependencies and operational support requirements.

Unified platforms that consolidate execution, data management and visibility can reduce system complexity and simplify ongoing operations. 

A Foundation for Digital Manufacturing

The right MES or manufacturing operations platform becomes part of the manufacturing itself. When selected thoughtfully, it supports connected operations, improved insight and continuous improvement across the production lifecycle.

This completes the series – from understanding MES as a foundation, to unlocking operational intelligence, to selecting a platform that enables both today’s requirements and tomorrow’s manufacturing goals.

Speak with our specialist and see TrackWise Manufacturing in action.

The post How to Choose the Right MES or Manufacturing Operations Platform appeared first on Honeywell.

]]>
Improving Manufacturing Performance – Moving Beyond OEE to Operational Intelligence https://www.spartasystems.com/resources/improving-manufacturing-performance-moving-beyond-oee-to-operational-intelligence/ Sun, 15 Mar 2026 11:18:47 +0000 https://www.spartasystems.com/?post_type=resources&p=23397 Overall Equipment Effectiveness (OEE) is widely used in pharmaceutical manufacturing to assess equipment availability, performance and quality. But in complex, regulated environments, improving performance requires more than retrospective metrics. It requires operational intelligence:

The post Improving Manufacturing Performance – Moving Beyond OEE to Operational Intelligence appeared first on Honeywell.

]]>

OEE Is a Starting Point, Not the Destination

In complex, regulated environments, improving performance requires more than retrospective metrics. It requires operational intelligence: the ability to interpret production conditions as they occur and respond before issues escalate.

Who this matters to:

  • Operations: Faster response to deviations
  • Engineering: Better root cause analysis
  • Quality: Improved contextual understanding of events
What OEE Tells You – and What it Doesn’t 

OEE combines three key factors: 

  • Availability
  • Performance
  • Quality

Together, these metrics provide a high-level view of how effectively equipment is being utilized. However, OEE is typically a lagging indicator, meaning it reflects performance after events have already occurred.

While valuable for measuring overall effectiveness, OEE alone does not provide full context around process conditions, material variability, or operator actions that may influence production outcomes. As a result, teams may understand that performance has changed, but additional operational insight is often required to determine why.

Why Operational Intelligence Matters

Pharmaceutical manufacturing generates large volumes of operational data across control systems, execution systems and batch records. When this information remains fragmented, teams struggle to interpret events in real-time.

Operational intelligence focuses on connecting these data sources to provide contextual visibility. Instead of isolated metrics, teams gain a coherent view of what is happening across equipment, processes and batches as production unfolds.

The Role of Real‑Time Process Visualization

Operational intelligence begins with visibility. Unified HMI/SCADA visualization allows operators and engineers to monitor equipment status, alarms, process variables and production progress in real-time.

A consistent visualization layer reduces operational complexity and improves situational awareness. When deviations occur, teams can identify and respond more quickly, rather than waiting for post-batch analysis.

Data Historians as a Foundation for Insight

A comprehensive data historian is essential for turning raw production data into insight. By combining batch and time‑series data, historians provide a complete view of both discrete and continuous processes.

This historical context enables advanced trending, comparison of production runs and more efficient investigations. Engineers and quality teams can move beyond what happened to understanding why it happened. 

From Reporting to Action

When execution data, visualization and historical context are unified, manufacturers can move from reactive performance management to proactive improvement. Operational intelligence supports faster root cause analysis, more informed collaboration across teams and continuous process refinement without compromising compliance.

OEE remains a useful indicator, but it is only the starting point. Operational intelligence is what turns performance data into sustained improvement.

In the final blog of this series, we explore how to evaluate and select an MES or manufacturing operations platform capable of supporting this level of insight and scalability.

Learn how operational intelligence builds on MES execution data

The post Improving Manufacturing Performance – Moving Beyond OEE to Operational Intelligence appeared first on Honeywell.

]]>
What is MES in Pharma Manufacturing? A Practical Guide https://www.spartasystems.com/resources/what-is-mes-in-pharma-manufacturing-a-practical-guide/ Sun, 15 Mar 2026 10:56:28 +0000 https://www.spartasystems.com/?post_type=resources&p=23396 Pharmaceutical and biotech manufacturers are operating in increasingly complex environments. Manufacturing Execution Systems (MES) have become essential infrastructure in this context.

The post What is MES in Pharma Manufacturing? A Practical Guide appeared first on Honeywell.

]]>

Why MES Matters More Than Ever in Life Sciences?

Manufacturing Execution Systems (MES) have become essential infrastructure in this context. They provide the real-time execution layer that connects people, processes and data across the shop floor, enabling traceability, consistency and regulatory compliance.

Who this matters to:

  • Operations: Consistent execution across shifts and sites
  • Quality: Reliable, inspection-ready records
  • IT: A scalable execution layer that integrates cleanly with enterprise systems
What an MES Does in Practice?

An MES sits between enterprise systems such as ERP and the shop-floor control layer, including HMI/SCADA and automation systems. While ERP focuses on planning and business transactions, MES manages how production is actually executed. 

In practical terms, MES coordinates materials, equipment and operators as production progresses. It captures process parameters, equipment states and operator actions at the moment work is performed, creating a structured, electronic record of manufacturing activities. This execution-level visibility is critical in pharmaceutical manufacturing, where complete and accurate documentation is mandatory.

A key outcome of MES is the creation of an “as-built” manufacturing record. Instead of reconstructing events after a batch is complete, MES records production history in real-time. This improves transparency during manufacturing and provides a reliable foundation for batch review, investigations and inspections.

Why Legacy Manufacturing Systems Fall Short?

Many life sciences manufacturers still rely on a combination of disconnected control systems, spreadsheets and manual data entry. Production data may be split across multiple sources: equipment events in automation systems, batch records in paper or PDFs and operator actions in logbooks. 

This limits visibility, slows decision‑making and increases data integrity risk. Manual transcription can introduce errors and delays, particularly during batch review and release. As production volumes and product complexity grow, these approaches become increasingly difficult to scale.

Core Capabilities of a Modern MES

A modern MES unified execution, data capture and visibility in a single environment. Core capabilities typically include:

Batch Management & Execution: MES coordinates and controls the execution of production batches based on predefined manufacturing instructions. This helps support consistent execution of approved workflows across production batches.

Recipe Authoring & Control: Digital recipe management allows manufacturers to define process parameters and instructions within a controlled environment. Once approved, these recipes guide operators through each step of the manufacturing process.

Material Tracking: MES provides full traceability of materials used during production. Raw materials, intermediates and finished products can be tracked throughout the manufacturing process, supporting product genealogy and traceability requirements.

Electronic Batch Records (eBR): Electronic batch records replace traditional paper documentation by capturing manufacturing data automatically during production. This reduces manual data entry, improves accuracy and accelerates batch review processes.

OEE Integration: Many MES platforms integrate Overall Equipment Effectiveness (OEE) monitoring to measure equipment availability, performance and quality. These insights help manufacturers identify bottlenecks, reduce downtime and continuously improve operational efficiency.

Together, these capabilities reduce manual effort, support consistent execution of approved procedures and provide a reliable data foundation for continuous improvement. 

Supporting Regulatory Compliance

Regulatory compliance is foundational in pharmaceutical manufacturing and MES plays a central role in supporting it. Modern MES platforms include built‑in audit trails, secure electronic records and system controls designed to support regulatory requirements such as 21 CFR Part 11.

By capturing data directly at the point of execution and maintaining complete, timestamped records, MES strengthens data integrity and simplifies inspection readiness. Rather than assembling documentation retrospectively, quality teams can review structured electronic records that reflect exactly how production occurred. 

The Business Impact of MES

Beyond compliance, MES delivers tangible business value. Manufacturers benefit from improved traceability, reduced batch release timelines and greater operational agility. Most importantly, MES provides a scalable digital foundation that supports long-term manufacturing transformation without adding any unnecessary system complexity.

MES is no longer optional in pharmaceutical manufacturing. It is essential infrastructure.

In the next blog, we look beyond execution and explore how manufacturers use this data foundation to move from basic performance metrics toward operational intelligence. 

Explore how MES fits into a modern pharmaceutical architecture.

The post What is MES in Pharma Manufacturing? A Practical Guide appeared first on Honeywell.

]]>
Leveraging Digitalization to Resolve Cell & Gene Therapy Manufacturing Challenges https://hcenews.honeywell.com/Manufacturing-Cell-Gene-Therapy.html#new_tab Sun, 12 Jan 2025 20:14:06 +0000 https://www.spartasystems.com/?post_type=resources&p=22570 Life Science organizations are adopting modular facilities to speed up time-to-market and simplify product updates. Discover how modular automation and integrated platforms can optimize production, improve efficiency, and enhance compliance. Learn how to reduce integration time by 30-50% in this insightful whitepaper.

The post Leveraging Digitalization to Resolve Cell & Gene Therapy Manufacturing Challenges appeared first on Honeywell.

]]>
The post Leveraging Digitalization to Resolve Cell & Gene Therapy Manufacturing Challenges appeared first on Honeywell.

]]>
Increasing Manufacturing Flexibility with the Incremental Adoption of a Modular Platform https://hcenews.honeywell.com/Manufacturing-Increasing-Flexibility.html Sun, 12 Jan 2025 20:07:09 +0000 https://www.spartasystems.com/?post_type=resources&p=22569 Life Science organizations are adopting modular facilities to speed up time-to-market and simplify product updates. Discover how modular automation and integrated platforms can optimize production, improve efficiency, and enhance compliance. Learn how to reduce integration time by 30-50% in this insightful whitepaper.

The post Increasing Manufacturing Flexibility with the Incremental Adoption of a Modular Platform appeared first on Honeywell.

]]>
The post Increasing Manufacturing Flexibility with the Incremental Adoption of a Modular Platform appeared first on Honeywell.

]]>
Providing Enhanced Manufacturing Data to Contracting Companies: A CDMO Challenge and Opportunity https://hcenews.honeywell.com/Manufacturing-CDMO.html Sun, 12 Jan 2025 19:56:38 +0000 https://www.spartasystems.com/?post_type=resources&p=22568 Discover how the growing CMO and CDMO sector, projected to exceed $220 billion by 2023, can leverage data packs to enhance batch reports and critical insights. Learn about a platform-based approach to streamline data capture, meet client demands, and improve manufacturing efficiency.

The post Providing Enhanced Manufacturing Data to Contracting Companies: A CDMO Challenge and Opportunity appeared first on Honeywell.

]]>
The post Providing Enhanced Manufacturing Data to Contracting Companies: A CDMO Challenge and Opportunity appeared first on Honeywell.

]]>
Modular Automation: The Plug and Produce Opportunity for Life Sciences https://hcenews.honeywell.com/Manufacturing-Modular-Automation.html Sun, 12 Jan 2025 19:51:08 +0000 https://www.spartasystems.com/?post_type=resources&p=22567 This whitepaper discusses the benefits of modular automation given the ongoing evolution to modular plants and what the industry dubs plug-and-produce processing. What standards should you be aware of as you make automation investments within the modular plant? How will modular technologies enable integration with component HMIs? What efficiency and cost impact can you expect to achieve?

The post Modular Automation: The Plug and Produce Opportunity for Life Sciences appeared first on Honeywell.

]]>

The post Modular Automation: The Plug and Produce Opportunity for Life Sciences appeared first on Honeywell.

]]>
3 Steps to Digital Transformation in Life Sciences Manufacturing https://hcenews.honeywell.com/Manufacturing-Digital-Transformation.html Fri, 26 Jul 2024 15:51:08 +0000 https://www.spartasystems.com/?post_type=resources&p=22123 Explore how a digital platform accelerates innovation in life sciences manufacturing, ensuring transparency, data integrity, and continuous improvement in this whitepaper.

The post 3 Steps to Digital Transformation in Life Sciences Manufacturing appeared first on Honeywell.

]]>
The post 3 Steps to Digital Transformation in Life Sciences Manufacturing appeared first on Honeywell.

]]>